Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease
Objectives: Fatigue is a complaint frequently encountered among patients with Parkinson’s disease (PD). Considering the possible relationship between fatigue and dopaminergic dysfuncion, we investigated the effect of pergolide mesilate (a D2 and D1 dopamine receptor agonist) and bromocriptine (a D2...
Saved in:
Main Authors: | Kazuo Abe, Mayako Takanashi, Takehiko Yanagihara, Sabro Sakoda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2002-01-01
|
Series: | Behavioural Neurology |
Online Access: | http://dx.doi.org/10.1155/2002/473140 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Camptocormia in Parkinson's Disease
by: Kazuo Abe, et al.
Published: (2010-01-01) -
Invalid Self-Assessment of Olfactory Functioning in Parkinson’s Disease Patients May Mislead the Neurologist
by: Nele Schmidt, et al.
Published: (2020-01-01) -
17.-18. YÜZYIL OSMANLI UYGULAMASINDA İRTİFAK HAKKI OLARAK MECRA VE MESİL HAKKI (SU AKITMA İRTİFAKI)
by: Melikşah Aydın
Published: (2025-01-01) -
Reliability and Validity of the Persian Version of the Fatigue Severity Scale in Idiopathic Parkinson’s Disease Patients
by: Seyed-Mohammad Fereshtehnejad, et al.
Published: (2013-01-01) -
Orthostatic Hypotension Is a Predictor of Fatigue in Drug-Naïve Parkinson’s Disease
by: Jong Hyeon Ahn, et al.
Published: (2023-01-01)